Neutron Safety at PET Cyclotron Facilities

Q: Why do PET cyclotrons produce neutrons?

Producing PET radionuclides requires accelerating protons (or deuterons) into a target, and the nuclear reactions that make the isotope — such as oxygen-18 plus a proton yielding fluorine-18 plus a neutron — release free neutrons. Competing reactions in the target, target holder, and beamline release additional neutrons, so intense fast-neutron fields are an unavoidable byproduct of production while the beam is on.

Q: Is a cyclotron vault occupied during operation?

No. Because neutron and gamma dose rates inside an operating cyclotron vault are extremely high, the vault is fully interlocked and unoccupied while the beam is on. Access is controlled by door interlocks tied to the beam, and shielding is designed so that occupied areas outside the vault stay within dose limits and ALARA goals.

Q: What shielding stops cyclotron neutrons?

Fast neutrons are best handled by first slowing them down in hydrogen-rich materials such as water, concrete, or polyethylene through elastic scattering, then capturing the slowed neutrons — borated polyethylene is favored because boron captures thermal neutrons with minimal energetic capture gamma rays. A complete design also attenuates the capture gammas and the 511 keV and other photons with dense material.

A PET cyclotron is the one place in a medical imaging enterprise where fast neutrons, not photons, dominate the radiation safety picture. The proton-induced reactions that make fluorine-18 and other PET radionuclides release intense neutron fields while the beam is on, and those neutrons activate the vault, the targetry, and even the air. Neutrons behave nothing like the 511 keV photons handled downstream in the PET suite — they carry a much higher biological weighting, they require hydrogen-rich shielding, and they leave a radioactive residue behind. That makes the cyclotron vault a neutron-first design problem.

Introduction

Most radiation safety in diagnostic imaging is a photon problem: X-ray tubes, 511 keV annihilation photons, and gamma-emitting radiopharmaceuticals. A PET cyclotron breaks that pattern. To manufacture a positron emitter, the machine accelerates protons to energies of roughly 9–18 MeV for a typical medical cyclotron and drives them into a target. The nuclear reactions that create the isotope release free neutrons, and those neutrons — fast, penetrating, and biologically potent — become the governing hazard. ³⁴

The canonical reaction for fluorine-18, the workhorse of PET, is $^{18} O (p, n)^{18} F$ : a proton strikes an oxygen-18 nucleus and a neutron comes out. Every atom of F-18 made this way is accompanied by a neutron, and additional neutrons come from competing reactions in the target, the target foil, the collimators, and the beamline. During beam-on, the vault holds an intense mixed neutron-and-gamma field. After beam-off, the neutrons that were absorbed by surrounding materials leave those materials radioactive — a phenomenon called activation. ³⁴⁶

This article explains where cyclotron neutrons come from, how their dose is quantified with neutron-specific weighting, how vaults are shielded, why activation matters, and how the program fits the regulatory framework. DRPS supports PET production and nuclear medicine facilities through its radiation shielding design and PET/CT and nuclear medicine physics services across Florida, Maryland, Virginia, Washington DC, California, Nevada, and beyond.

Topic Explanation

Where cyclotron neutrons come from

Neutrons are an unavoidable byproduct of accelerating charged particles into a production target. The reactions used to make PET radionuclides are neutron-producing by nature, and the neutron yield rises with beam current and energy. ³⁴

The principal PET-production reactions and their neutron sources include:

$^{18} O (p, n)^{18} F$ — fluorine-18 from oxygen-18-enriched water, the dominant clinical reaction. ⁴
$^{14} N (p, α)^{11} C$ and related reactions for carbon-11, nitrogen-13, and oxygen-15.
Parasitic reactions in the target body, foils, collimators, and beam stops, where stray protons and secondary particles generate additional neutrons.

The emitted neutrons span a wide energy spectrum, but for a low-energy medical cyclotron the field is dominated by fast neutrons in the roughly 0.1–10 MeV range. This is important because fast neutrons carry the highest biological weighting and are the hardest to shield — they must be slowed down before they can be efficiently captured. ¹³

Prompt radiation versus activation

A cyclotron facility has two distinct radiation regimes:

Prompt radiation — the neutron and gamma field present only while the beam is on. Dose rates in the vault during production are extremely high, which is why the vault is interlocked and never occupied during beam-on. ³
Activation (residual) radiation — neutrons absorbed by the vault concrete, cyclotron components, cooling water, and air create radioactive nuclei that persist after beam-off. A gamma-spectrometry study of a medical cyclotron vault identified activation products including europium-152, europium-154, cesium, zinc, and cobalt isotopes in the walls, and measured a maximum residual surface dose rate of about 1.2 µSv/h — low, but non-zero and cumulative over the life of the facility. ⁶

Activation is what makes cyclotron maintenance, component replacement, and eventual decommissioning a radiation-protection task in their own right, long after any single production run. For the general framework of decay and residual activity, see our discussion of decay-in-storage for radioactive waste.

Related terms

Absorbed dose ( $D$ ) — energy deposited per unit mass, in gray (Gy).
Radiation weighting factor ( $w_{R}$ ) — a factor that converts absorbed dose into equivalent dose to reflect biological effectiveness; energy-dependent for neutrons. ¹
Equivalent dose ( $H_{T}$ ) — $w_{R}$ times absorbed dose, in sievert (Sv).
Fluence ( $ϕ$ ) — the number of neutrons crossing a unit area, in neutrons per cm².
Moderation — slowing fast neutrons through elastic collisions, primarily with hydrogen.

Key Technical Principles

The neutron radiation weighting factor

Neutrons are more biologically damaging per unit absorbed dose than photons, and their effectiveness depends strongly on energy. ICRP Publication 103 defines the neutron radiation weighting factor as a continuous function of neutron energy $E_{n}$ (in MeV). For the fast-neutron range most relevant to a medical cyclotron: ¹

w_{R} = 5.0 + 17.0 exp [- \frac{( ln ( 2 E _{n} ) ) ^{2}}{6}], 1 \leq E_{n} \leq 50 MeV

This function peaks near $E_{n} \approx 1$ MeV, exactly where much of the cyclotron neutron spectrum sits.

Worked example. For a 1 MeV neutron:

w_{R} = 5.0 + 17.0 exp [- \frac{( ln 2 ) ^{2}}{6}] = 5.0 + 17.0 exp (- 0.0801) \approx 5.0 + 15.7 \approx 20.7

So a fast neutron near 1 MeV carries a weighting factor of about 20 — twenty times that of a photon. By contrast, a thermal neutron (energy near 0.025 eV) has a weighting factor of only about 2.5. This enormous energy dependence is the physical reason vault shielding is designed to moderate fast neutrons rather than simply attenuate them. ¹

From absorbed dose to equivalent dose

Equivalent dose follows directly from the weighting factor:

H_{T} = w_{R} \cdot D

Using the worked value above, 1 mGy of absorbed dose from ~1 MeV neutrons corresponds to:

H_{T} = 20.7 \times 1 mGy \approx 20.7 mSv

The same 1 mGy delivered by photons would be about 1 mSv. This factor-of-twenty difference is why an unshielded neutron field that looks modest in absorbed-dose terms can be a serious equivalent-dose hazard, and why neutron and gamma contributions must be evaluated separately, not lumped together. ¹

Fluence-to-dose conversion

In practice, neutron fields are characterized by fluence and spectrum, and converted to effective dose using energy-dependent conversion coefficients. The effective dose from a spectrum of neutron fluences is:

E = i \sum ϕ_{i} \cdot h_{ϕ} (E_{i})

where $ϕ_{i}$ is the fluence in each energy bin and $h_{ϕ} (E_{i})$ is the fluence-to-effective-dose conversion coefficient tabulated in ICRP Publication 116. For fast neutrons near 1 MeV these coefficients are on the order of several hundred pSv·cm² per unit fluence, rising with energy through the fast region. Using the correct spectrum-weighted coefficient matters, because a single generic factor can misstate the dose by a large margin across the neutron spectrum. ²

Neutron shielding physics

Fast neutrons cannot be stopped efficiently by dense metal the way photons can. The strategy is a two-step sequence: moderate, then capture. ³⁵

Moderate. A fast neutron loses the most energy per collision when it scatters off a nucleus of similar mass — hydrogen. Hydrogen-rich materials such as water, concrete (which contains bound water), and polyethylene are efficient moderators, dropping fast neutrons toward thermal energies over successive elastic collisions.
Capture. Once thermalized, neutrons are readily absorbed. Boron-10 has a large thermal-capture cross-section and — importantly — releases only a low-energy (0.478 MeV) capture gamma, whereas capture on hydrogen produces an energetic 2.2 MeV gamma that then needs its own shielding. This is why borated polyethylene is a favored neutron shield.
Attenuate secondary photons. The prompt gammas, capture gammas, and 511 keV photons are handled with dense material such as lead or steel — with the caveat that steel itself can become activated.

Neutron energy category	Approximate energy	$w_{R}$ (ICRP 103)	Shielding role
Thermal	~0.025 eV	~2.5	Captured by boron, cadmium, hydrogen; produces capture gammas
Epithermal	~0.5 eV – 10 keV	rising	Moderation continues toward thermal
Fast	~0.1 – 10 MeV	up to ~20 (peak near 1 MeV)	Dominant hazard; must be moderated before capture
High-energy	> 20 MeV	declining	Minor for low-energy medical cyclotrons

Shielding material	Primary role	Mechanism
Water / polyethylene	Moderate fast neutrons	Elastic scatter off hydrogen
Borated polyethylene	Moderate and capture	Hydrogen moderation plus boron-10 capture with low-energy capture gamma
Concrete (often thick or heavy)	Bulk vault barrier	Water content moderates; mass attenuates
Lead / steel	Attenuate capture and 511 keV photons	Photoelectric and Compton interactions (steel may activate)

Medical cyclotrons are supplied either as self-shielded units — the shield travels with the machine and it can sit in a conventional room — or as unshielded machines installed inside a purpose-built vault with thick concrete walls and a shielded access maze. The choice affects footprint, cost, activation, and the shielding calculation, and it should be matched to beam energy, production workload, and adjacent occupancy. ³⁴ The same barrier-physics discipline underlies photon shielding downstream; see our PET/CT shielding calculations guide and lead shielding design principles.

Clinical Impact

The neutron hazard shapes the entire physical plant of a PET production facility, not just a single wall. Because in-vault dose rates during beam-on are prohibitive, the vault is interlocked and unoccupied, and the shielding must protect the adjacent radiopharmacy, control room, offices, and any spaces above and below. A self-shielded cyclotron in a medical office building and an unshielded machine in a concrete vault present very different design and occupancy problems, and both must satisfy the same dose limits at the occupied points. ³⁴

Activation adds a time dimension that photon-only facilities do not face. Vault concrete, the cyclotron itself, target hardware, cooling water, and the vault air all accumulate activation products over the operating life of the facility. That has direct operational consequences: maintenance and target changes must be planned around residual dose rates and short-lived activation decay, activated components become radioactive waste, and decommissioning a cyclotron is a materials-license action requiring activation surveys. ⁶ Even the measured residual surface dose rates — around 1 µSv/h in one vault study — are low individually but drive access, maintenance timing, and waste decisions across years of operation. ⁶

Personnel protection is also different in a mixed field. Standard photon dosimeters do not correctly measure neutron dose, so staff who could be exposed to neutron fields need dosimetry appropriate to mixed neutron-gamma environments, and the RSO must know which areas and tasks carry neutron exposure potential. For the broader monitoring framework, see occupational exposure monitoring.

Practical Optimization Tips

1. Design the vault around fast-neutron moderation

Treat fast-neutron moderation as the primary design driver. Use hydrogen-rich bulk shielding (concrete, and borated polyethylene where localized capture is needed), and only then add dense material for the secondary photon field. A shield optimized for photons alone will underperform against neutrons. ³⁵

2. Account for activation from the start

Plan for activation of concrete, components, cooling water, and air in the initial design: choose low-activation materials where practical, provide for decay of short-lived activation before maintenance, and design ventilation to manage activated air (for example, nitrogen-13 and oxygen-15). Build activation surveys into the routine program. ⁴⁶

3. Interlock the vault to the beam

Door interlocks tied to beam status are non-negotiable — the vault must be incapable of being occupied during beam-on. Verify interlock function on a defined schedule and document it. Access control is the single most important engineered protection against the prompt neutron field. ³

4. Use neutron-appropriate monitoring and dosimetry

Survey the facility with instruments that respond correctly to neutrons (for example, moderated rem-meters), not photon-only meters, and assign neutron-capable personnel dosimetry to staff with exposure potential. Confirm instrument energy response is suitable for the cyclotron spectrum. Our guide to choosing the right radiation survey meter covers instrument selection.

5. Verify the installed shield and keep occupancy honest

Confirm the as-built shield with post-installation neutron and gamma surveys at the occupied points, under realistic production workload. Re-evaluate if beam current, isotope mix, or adjacent occupancy changes — a room labeled "storage" that later becomes a full-time office changes the design basis. ³⁴

Common pitfalls to avoid

Shielding for photons and assuming neutrons follow. Neutrons need moderation first; dense metal alone is inefficient.
Ignoring capture gammas. Hydrogen capture yields a 2.2 MeV gamma that needs its own attenuation.
Forgetting activation. The vault and hardware stay radioactive after beam-off and become a waste and decommissioning issue.
Using photon-only dosimetry in a neutron field. It underestimates dose to staff.
Fixing occupancy assumptions in ink. Workload and adjacent-area use change; the design basis must be revisited. ³⁴⁶

Regulatory Considerations

A cyclotron facility operates under a radioactive material license and the federal or Agreement State rules for byproduct and accelerator-produced material, with dose limits and ALARA setting the shielding design goals. ⁷⁸

Key frameworks:

10 CFR Part 20 — Standards for Protection Against Radiation. Occupational dose limits, public dose limits, and ALARA set the design goals for vault barriers and access controls; the annual occupational limit and the more restrictive public limit both apply at the appropriate points. ⁷
10 CFR Part 35 and materials licensing. Medical use of the produced radionuclides falls under medical-use licensing; accelerator-produced radioactive material is regulated as byproduct material under NRC or Agreement State authority. ⁸
ICRP Publications 103 and 116. The radiation weighting factors and fluence-to-dose conversion coefficients that make neutron dose assessment defensible. ¹²
IAEA guidance. IAEA guidance on cyclotron facility design and FDG production addresses shielding, activation, ventilation, and radiation safety expectations for setting up a production facility. ⁴
NCRP Report No. 151. Structural shielding design methodology for facilities where neutron and high-energy photon shielding must be evaluated together. ⁵

Jurisdiction depends on the state. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, New York, New Jersey, and Pennsylvania are NRC Agreement States that license accelerator-produced and byproduct material under their own radiation-control rules — in Florida, under Chapter 64E-5, Florida Administrative Code — while Washington DC and Delaware are regulated directly by the NRC. A facility must confirm which authority issues its license and which dose limits, survey, and reporting requirements apply. ⁷⁸ For the RSO's central role, see the radiation safety officer's responsibilities.

Frequently Asked Questions (FAQs)

Why do PET cyclotrons produce neutrons?

Producing PET radionuclides requires accelerating protons into a target, and the reactions that make the isotope — such as oxygen-18 plus a proton yielding fluorine-18 plus a neutron — release free neutrons. Competing reactions in the target and beamline release more, so intense fast-neutron fields are an unavoidable byproduct while the beam is on.

Are neutrons more dangerous than the gamma rays from PET isotopes?

Per unit absorbed dose, fast neutrons are more biologically damaging. ICRP assigns fast neutrons a radiation weighting factor up to about 20, so 1 mGy of fast-neutron absorbed dose is treated as roughly 20 mSv of equivalent dose, versus a weighting factor of 1 for photons. That is why neutron fields dominate vault shielding design.

What is cyclotron activation?

Neutrons produced during operation are captured by the nuclei of the vault walls, cyclotron components, air, and cooling water, turning stable atoms radioactive. This activation means the vault and equipment remain a residual radiation source after beam-off and must be accounted for in maintenance, waste, and decommissioning.

Is a cyclotron vault occupied during operation?

No. Neutron and gamma dose rates inside an operating vault are extremely high, so the vault is fully interlocked and unoccupied during beam-on. Access is controlled by door interlocks tied to the beam, and shielding keeps occupied areas outside the vault within dose limits and ALARA goals.

What shielding stops cyclotron neutrons?

Fast neutrons are first slowed in hydrogen-rich materials such as water, concrete, or polyethylene through elastic scattering, then captured — borated polyethylene is favored because boron captures thermal neutrons with minimal energetic capture gamma. A complete design also attenuates capture gammas and 511 keV photons with dense material.

Who oversees radiation safety at a cyclotron facility?

A Radiation Safety Officer, supported by a qualified medical physicist, oversees the program under the facility's radioactive material license — neutron and gamma monitoring, activation surveys, mixed-field personnel dosimetry, shielding verification, and ALARA, all documented for NRC or Agreement State review.

Key Takeaways

Neutrons, not photons, govern cyclotron shielding. Proton-induced production reactions release intense fast-neutron fields during beam-on. ³⁴
Fast neutrons carry a weighting factor up to about 20. Equivalent dose can be twenty times the absorbed dose, versus one for photons. ¹
Shield by moderate-then-capture. Hydrogen-rich moderation followed by boron capture, then dense material for secondary photons. ³⁵
Activation is a lasting hazard. The vault, components, water, and air become radioactive and drive maintenance, waste, and decommissioning. ⁶
Mixed fields need neutron-appropriate monitoring. Photon-only meters and dosimeters understate neutron dose. ¹²
Interlocks and honest occupancy are essential. The vault is never occupied during beam-on, and the design basis must be revisited when workload or occupancy changes. ³⁴

Conclusion

A PET cyclotron inverts the usual radiation safety intuition of a diagnostic imaging enterprise. Downstream, the hazard is 511 keV photons; at the cyclotron, it is fast neutrons with a biological weighting up to twenty times higher, a shielding problem that demands moderation before attenuation, and an activation legacy that outlives any single production run. A defensible program treats the vault as a neutron-first design, plans for activation from day one, interlocks access to the beam, monitors the mixed field with the right instruments, and documents the whole basis against 10 CFR Part 20, ICRP weighting and conversion data, and the applicable NRC or Agreement State requirements. Done well, it lets a facility manufacture the isotopes that power modern PET while keeping staff and the public safely below dose limits. ¹³⁴

How DRPS Can Help

Diagnostic Radiation Physics Services supports PET production and nuclear medicine facilities with cyclotron and vault radiation shielding design, neutron and gamma shielding evaluation, activation and residual-dose surveys, post-installation verification, mixed-field monitoring and dosimetry program support, and radioactive material license support and RSO consulting aligned with NRC and Agreement State requirements — all delivered by board-certified medical physicists.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A strong cyclotron radiation safety program makes the neutron hazard visible, quantified, and controlled — not an afterthought behind the photon shielding.

Related Resources

References

International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP. 2007;37(2-4). icrp.org
International Commission on Radiological Protection. Conversion Coefficients for Radiological Protection Quantities for External Radiation Exposures. ICRP Publication 116. Ann ICRP. 2010;40(2-5). icrp.org
International Atomic Energy Agency. Cyclotron Produced Radionuclides: Principles and Practice. Technical Reports Series No. 465. Vienna: IAEA; 2008. iaea.org
International Atomic Energy Agency. Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of [18F]Fluorodeoxyglucose (FDG). IAEA Radioisotopes and Radiopharmaceuticals Series No. 3. Vienna: IAEA; 2012. iaea.org
National Council on Radiation Protection and Measurements. Structural Shielding Design and Evaluation for Megavoltage X- and Gamma-Ray Radiotherapy Facilities. NCRP Report No. 151. Bethesda, MD: NCRP; 2005. aapm.org
Abuhoza AA, Kassim HA, Alghamdi AA, et al. Identification of activation isotopes in a CS-30 cyclotron vault. Sensors (Basel). 2022;22(7):2581. doi:10.3390/s22072581. doi.org
U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. ecfr.gov